close

Location

345 Park Ave South,
New York, NY 10010
(212) 547-9879

Investors

Lexeo Therapeutics, taking aim at the cause of genetic diseases

Lexeo

COMPANY Profile

Lexeo Therapeutics is a New York City based clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated.

MORE INFORMATION

News Releases

Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference

Read More

Lexeo Therapeutics to Participate in Upcoming Investor Conferences in February

Read More

Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics

Read More
All Press releases

Events

Leerink Global Healthcare Conference

Listen to webcast

Oppenheimer 36th Annual Healthcare Life Sciences Conference

Listen to Webcast
All Events

Contact Us